| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | ANTLIA BIOSCIENCE, INC. | 1281 HYMETTUS AVE | ENCINITAS | CA | 92024-1745 | SAN DIEGO | USA | R44HL169016 | A novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (hBNP), to treat resistant hypertension | 000 | 1 | NIH | 10/9/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $999,998 ) |
| | 2024 | 2024 | ANTLIA BIOSCIENCE, INC. | 1281 HYMETTUS AVE | ENCINITAS | CA | 92024-1745 | SAN DIEGO | USA | R44HL169016 | A novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (hBNP), to treat resistant hypertension | 000 | 1 | NIH | 9/18/2024 | $999,998 |
|
|
